Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy.
We describe a patient with confirmed novel H1N1 (swine-like) influenza A virus who had daily nasal swabs tested during oseltamivir therapy. Nasal shedding remained positive for 2 days and became negative on day 3. This report presents the first available data on the kinetics of shedding of this novel virus under antiviral therapy.
Charlier
C
C
Université Paris Descartes, Service de Maladies Infectieuses et Tropicales, Centre d'Infectiologie Necker-Pasteur, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
Enouf
V
V
Lanternier
F
F
Grandadam
M
M
Amazzough
K
K
Blanche
S
S
Lecuit
M
M
Lortholary
O
O
van der Werf
S
S
D000328:Adult; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D006801:Humans; D007121:Immunocompetence; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology*; D007251:Influenza, Human / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology; D007700:Kinetics; D008297:Male; D009305:Nasopharynx / Q000821:virology*; D053139:Oseltamivir / Q000627:therapeutic use*; D013552:Swine; D017201:Virus Shedding
D000998:Antiviral Agents; D053139:Oseltamivir